Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma

BACKGROUND: The introduction of immune checkpoint inhibitors has led to a survival benefit in patients with advanced melanoma; however data on the adoption of immunotherapy in the community are scarce. METHODS: Using the National Cancer Database, we identified 4725 patients aged ≥20 diagnosed with m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Krimphove, Marieke J., Tully, Karl H., Friedlander, David F., Marchese, Maya, Ravi, Praful, Lipsitz, Stuart R., Kilbridge, Kerry L., Kibel, Adam S., Kluth, Luis A., Ott, Patrick A., Choueiri, Toni K., Trinh, Quoc-Dien
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6836520/
https://ncbi.nlm.nih.gov/pubmed/31699149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0782-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados